HopeStage
Back to all studies
CompletedNCT00723060

Two escitalopram doses for obsessive-compulsive disorder

About this title

Comparison of Effects Between Conventional Dose and High Dose Escitalopram on Clinical Improvement in Patients With Obsessive-compulsive Disorder

Read the official source — NCT00723060
Medication studyAges 18–65South KoreaOCD
The study in practice

Understand this study

Who was this study for?

This study was for people with OCD. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.

Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateSeptember 2008
Recruitment status
Completed
Enrollment listed in the registry
176
Sponsor
Seoul National University Hospital
Sponsor type
Hospital / academic medical center
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
South Korea
Age range
From 18 Years to 65 Years
Official registry ID
NCT00723060
Official title
Show the full official title

Comparison of Effects Between Conventional Dose and High Dose Escitalopram on Clinical Improvement in Patients With Obsessive-compulsive Disorder (Randomized, Double-blind, Multi-center Study)

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Seoul

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Seoul National University Hospital, a hospital or academic medical center.

Did this study involve medication?

Yes. The study involved medication, including escitalopram.

Who was this study for?

This study was for people with OCD. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies